SCHEMBL18334657

SCHEMBL18334657

O=C(CC[C@@H](F)C(=O)O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
MAPK1 P28482 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KMT2A Q03164 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
LMNA P02545 2/20 0.46
CDC25B P30305 1/20 0.46
SLC15A1 P46059 2/20 0.45
MEN1 O00255 2/20 0.44
HPGD P15428 1/20 0.44
NOTUM Q6P988 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18334656 1.00 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18334359 0.91 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18334358 0.91 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18803445 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18334350 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18334351 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18334381 0.86 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18334380 0.86 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL28277844 0.85 ALDH1A1 (0.59) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18334330 0.83 ALDH1A1 (0.58) ALDH1A1MAPK1L3MBTL1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3109230-B1 CLASS OF CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN PREPARATION OF PRODRUGS LI QINGENG (CN) 2019-11-20 EP claimed
US-10239851-B2 Carboxylic acid derivatives and use thereof in the preparation of prodrugs Li, Qingeng (CN) 2019-03-26 US claimed
US-20170057939-A1 CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN THE PREPARATION OF PRODRUGS LI, Qingeng (CN) 2017-03-02 US claimed
EP-3109230-B1 CLASS OF CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN PREPARATION OF PRODRUGS LI QINGENG (CN) 2019-11-20 EP disclosed
US-10239851-B2 Carboxylic acid derivatives and use thereof in the preparation of prodrugs Li, Qingeng (CN) 2019-03-26 US disclosed
US-9643917-B2 Water-soluble propofol derivatives and uses thereof JIANGSU NHWALUOKANG PHARMCEUTICAL RESEARCH AND DEVELOPMENT CO., LTD (CN) 2017-05-09 US disclosed
US-20170057939-A1 CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN THE PREPARATION OF PRODRUGS LI, Qingeng (CN) 2017-03-02 US disclosed
EP-3109230-A1 CLASS OF CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN PREPARATION OF PRODRUGS Li, Qingeng (CN) 2016-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10239851-B2 Carboxylic acid derivatives and use thereof in the preparation of prodrugs NR4A3, HCAR3, FFAR3 ALDH1A1 932/4885MAPK1 2962/4885L3MBTL1 4064/4885
US-20170057939-A1 CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN THE PREPARATION OF PRODRUGS NR4A3, HCAR3, NR4A2 ALDH1A1 897/4885MAPK1 2921/4885L3MBTL1 4039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.